P388 leukemia in [CDF.sub.1] mice as the test system for studies of tumor-associated neoangiogenesis and hypercoagulation

Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in [CDF.sub.1] mice with transplanted P-388 lymphocytic leukemia. Blood levels of vascular endothelial growth factor increased by 168% in mice with tumors. The animal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of experimental biology and medicine 2015-02, Vol.158 (4), p.497
Hauptverfasser: Trashkov, A.P, Panchenko, A.V, Kayukova, E.S, Korablev, R.V, Pechatnikova, V.A, Vasilev, A.G, Anisimov, V.N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 497
container_title Bulletin of experimental biology and medicine
container_volume 158
creator Trashkov, A.P
Panchenko, A.V
Kayukova, E.S
Korablev, R.V
Pechatnikova, V.A
Vasilev, A.G
Anisimov, V.N
description Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in [CDF.sub.1] mice with transplanted P-388 lymphocytic leukemia. Blood levels of vascular endothelial growth factor increased by 168% in mice with tumors. The animals developed the hypercoagulation syndrome manifesting in shorter activated partial thromboplastin time and prothrombin time and development of hyperfibrinogenemia. Key Words: tumor; hemostasis; neoangiogenesis; vascular endothelial growth factor; P-388 leukemia
doi_str_mv 10.1007/s10517-015-2793-0
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A455286977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A455286977</galeid><sourcerecordid>A455286977</sourcerecordid><originalsourceid>FETCH-LOGICAL-g987-25b1a9759aa9bf122981c33a1ca8212862dfb4ce8246e690f2493cab881e11403</originalsourceid><addsrcrecordid>eNptkE1LxDAQhnNQcF39Ad4CgrfWJP1Kjsv6CQt62JvIMk2nbbRtpJMe9t_bRQ8ryByGeed5X5hh7EqKWApR3JIUmSwiIbNIFSaJxAlbiHkRpVrrM3ZO9HEYRS4XbP-aaM07nD6xd8DdwN_Wdw8xTWUs33nvLHIgHlrkASlw2lPAntd-5BSmyiFxX_Mw9X6MgMhbBwErPqCHoXG-wQHJEYeh4u3-C0froZk6CM4PF-y0ho7w8rcv2fbhfrt-ijYvj8_r1SZqjC4ilZUSTJEZAFPWUimjpU0SkBa0kkrnqqrL1KJWaY65EbVKTWKh1FqilKlIluz6J7aBDnduqH0YwfaO7G6VZtmcYIpipuJ_qLmq-S3WD1i7Wf9juDkytAhdaMl30-EyOga_AQMLeXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P388 leukemia in [CDF.sub.1] mice as the test system for studies of tumor-associated neoangiogenesis and hypercoagulation</title><source>SpringerLink Journals - AutoHoldings</source><creator>Trashkov, A.P ; Panchenko, A.V ; Kayukova, E.S ; Korablev, R.V ; Pechatnikova, V.A ; Vasilev, A.G ; Anisimov, V.N</creator><creatorcontrib>Trashkov, A.P ; Panchenko, A.V ; Kayukova, E.S ; Korablev, R.V ; Pechatnikova, V.A ; Vasilev, A.G ; Anisimov, V.N</creatorcontrib><description>Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in [CDF.sub.1] mice with transplanted P-388 lymphocytic leukemia. Blood levels of vascular endothelial growth factor increased by 168% in mice with tumors. The animals developed the hypercoagulation syndrome manifesting in shorter activated partial thromboplastin time and prothrombin time and development of hyperfibrinogenemia. Key Words: tumor; hemostasis; neoangiogenesis; vascular endothelial growth factor; P-388 leukemia</description><identifier>ISSN: 0007-4888</identifier><identifier>DOI: 10.1007/s10517-015-2793-0</identifier><language>eng</language><publisher>Springer</publisher><subject>Blood tests ; Cancer research ; Endothelium ; Hypercoagulation ; Leukemia ; Prothrombin ; Thrombin ; Vascular endothelial growth factor</subject><ispartof>Bulletin of experimental biology and medicine, 2015-02, Vol.158 (4), p.497</ispartof><rights>COPYRIGHT 2015 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Trashkov, A.P</creatorcontrib><creatorcontrib>Panchenko, A.V</creatorcontrib><creatorcontrib>Kayukova, E.S</creatorcontrib><creatorcontrib>Korablev, R.V</creatorcontrib><creatorcontrib>Pechatnikova, V.A</creatorcontrib><creatorcontrib>Vasilev, A.G</creatorcontrib><creatorcontrib>Anisimov, V.N</creatorcontrib><title>P388 leukemia in [CDF.sub.1] mice as the test system for studies of tumor-associated neoangiogenesis and hypercoagulation</title><title>Bulletin of experimental biology and medicine</title><description>Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in [CDF.sub.1] mice with transplanted P-388 lymphocytic leukemia. Blood levels of vascular endothelial growth factor increased by 168% in mice with tumors. The animals developed the hypercoagulation syndrome manifesting in shorter activated partial thromboplastin time and prothrombin time and development of hyperfibrinogenemia. Key Words: tumor; hemostasis; neoangiogenesis; vascular endothelial growth factor; P-388 leukemia</description><subject>Blood tests</subject><subject>Cancer research</subject><subject>Endothelium</subject><subject>Hypercoagulation</subject><subject>Leukemia</subject><subject>Prothrombin</subject><subject>Thrombin</subject><subject>Vascular endothelial growth factor</subject><issn>0007-4888</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptkE1LxDAQhnNQcF39Ad4CgrfWJP1Kjsv6CQt62JvIMk2nbbRtpJMe9t_bRQ8ryByGeed5X5hh7EqKWApR3JIUmSwiIbNIFSaJxAlbiHkRpVrrM3ZO9HEYRS4XbP-aaM07nD6xd8DdwN_Wdw8xTWUs33nvLHIgHlrkASlw2lPAntd-5BSmyiFxX_Mw9X6MgMhbBwErPqCHoXG-wQHJEYeh4u3-C0froZk6CM4PF-y0ho7w8rcv2fbhfrt-ijYvj8_r1SZqjC4ilZUSTJEZAFPWUimjpU0SkBa0kkrnqqrL1KJWaY65EbVKTWKh1FqilKlIluz6J7aBDnduqH0YwfaO7G6VZtmcYIpipuJ_qLmq-S3WD1i7Wf9juDkytAhdaMl30-EyOga_AQMLeXA</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Trashkov, A.P</creator><creator>Panchenko, A.V</creator><creator>Kayukova, E.S</creator><creator>Korablev, R.V</creator><creator>Pechatnikova, V.A</creator><creator>Vasilev, A.G</creator><creator>Anisimov, V.N</creator><general>Springer</general><scope/></search><sort><creationdate>20150201</creationdate><title>P388 leukemia in [CDF.sub.1] mice as the test system for studies of tumor-associated neoangiogenesis and hypercoagulation</title><author>Trashkov, A.P ; Panchenko, A.V ; Kayukova, E.S ; Korablev, R.V ; Pechatnikova, V.A ; Vasilev, A.G ; Anisimov, V.N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g987-25b1a9759aa9bf122981c33a1ca8212862dfb4ce8246e690f2493cab881e11403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Blood tests</topic><topic>Cancer research</topic><topic>Endothelium</topic><topic>Hypercoagulation</topic><topic>Leukemia</topic><topic>Prothrombin</topic><topic>Thrombin</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trashkov, A.P</creatorcontrib><creatorcontrib>Panchenko, A.V</creatorcontrib><creatorcontrib>Kayukova, E.S</creatorcontrib><creatorcontrib>Korablev, R.V</creatorcontrib><creatorcontrib>Pechatnikova, V.A</creatorcontrib><creatorcontrib>Vasilev, A.G</creatorcontrib><creatorcontrib>Anisimov, V.N</creatorcontrib><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trashkov, A.P</au><au>Panchenko, A.V</au><au>Kayukova, E.S</au><au>Korablev, R.V</au><au>Pechatnikova, V.A</au><au>Vasilev, A.G</au><au>Anisimov, V.N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P388 leukemia in [CDF.sub.1] mice as the test system for studies of tumor-associated neoangiogenesis and hypercoagulation</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><date>2015-02-01</date><risdate>2015</risdate><volume>158</volume><issue>4</issue><spage>497</spage><pages>497-</pages><issn>0007-4888</issn><abstract>Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in [CDF.sub.1] mice with transplanted P-388 lymphocytic leukemia. Blood levels of vascular endothelial growth factor increased by 168% in mice with tumors. The animals developed the hypercoagulation syndrome manifesting in shorter activated partial thromboplastin time and prothrombin time and development of hyperfibrinogenemia. Key Words: tumor; hemostasis; neoangiogenesis; vascular endothelial growth factor; P-388 leukemia</abstract><pub>Springer</pub><doi>10.1007/s10517-015-2793-0</doi></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2015-02, Vol.158 (4), p.497
issn 0007-4888
language eng
recordid cdi_gale_infotracmisc_A455286977
source SpringerLink Journals - AutoHoldings
subjects Blood tests
Cancer research
Endothelium
Hypercoagulation
Leukemia
Prothrombin
Thrombin
Vascular endothelial growth factor
title P388 leukemia in [CDF.sub.1] mice as the test system for studies of tumor-associated neoangiogenesis and hypercoagulation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T18%3A30%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P388%20leukemia%20in%20%5BCDF.sub.1%5D%20mice%20as%20the%20test%20system%20for%20studies%20of%20tumor-associated%20neoangiogenesis%20and%20hypercoagulation&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Trashkov,%20A.P&rft.date=2015-02-01&rft.volume=158&rft.issue=4&rft.spage=497&rft.pages=497-&rft.issn=0007-4888&rft_id=info:doi/10.1007/s10517-015-2793-0&rft_dat=%3Cgale%3EA455286977%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A455286977&rfr_iscdi=true